Iterum Therapeutics plc — Quarterly Financial Statistics (NASDAQ:ITRM)

Financials

Cash from operating activities -4.26 M-3.06 M-4.75 M-7.45 M -19.51 M Cash from investing activities 1.1 M-2 0000-12 K 1.09 M Cash from financing activities 13.88 M-8.39 M5.12 M5.43 M 16.04 M Free cash flow -4.26 M-3.06 M-4.75 M-7.46 M -19.53 M

뉴스

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.72%

Iterum Therapeutics, 나스닥 상장 폐지 통보 후 청문회 요청

Iterum Therapeutics requests Nasdaq hearing after delisting notice

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.83%

이테룸 테라퓨틱스, ORLYNVAH® Medicare Part D 접근성 확대

Iterum Therapeutics expands Medicare Part D access for ORLYNVAH

Iterum Therapeutics expands market access for ORLYNVAH antibiotic

이테룸 테라퓨틱스, 주요 PBM 계약 체결

Iterum Therapeutics secures major PBM agreement for antibiotic

Iterum, 나스닥 상장 요건 미달 통보 받아

Iterum Therapeutics receives Nasdaq notice on listing compliance

이테룸 테라퓨틱스, ORLYNVAH 보험 적용 범위 확대